BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 29236302)

  • 1. Recovery of hepatitis C specific T-cell responses after rituximab therapy in hepatitis C mixed cryoglobulinemic vasculitis.
    Mathur P; Emmanuel B; Sneller M; Zhang X; Poonia B; Kottilil S
    J Med Virol; 2018 May; 90(5):936-941. PubMed ID: 29236302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decline of cellular activation in non-B cells after rituximab treatment in hepatitis C-associated mixed cryoglobulinemia vasculitis.
    Emmanuel B; Sidique N; Zhang X; Poonia B; Sneller MC; Kottilil S
    J Viral Hepat; 2017 Feb; 24(2):128-131. PubMed ID: 27666584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis.
    Saadoun D; Rosenzwajg M; Landau D; Piette JC; Klatzmann D; Cacoub P
    Blood; 2008 Jun; 111(11):5334-41. PubMed ID: 18292291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dilemma of treating hepatitis C virus-associated cryoglobulinemia.
    Roccatello D; Fenoglio R; Sciascia S
    Curr Opin Rheumatol; 2019 Sep; 31(5):499-504. PubMed ID: 31090590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
    Benstead TJ; Chalk CH; Parks NE
    Cochrane Database Syst Rev; 2014 Dec; (12):CD010404. PubMed ID: 25525951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of WA B cells in hepatitis C virus infection: a potential prognostic marker for cryoglobulinemic vasculitis and B cell malignancies.
    Knight GB; Gao L; Gragnani L; Elfahal MM; De Rosa FG; Gordon FD; Agnello V
    Arthritis Rheum; 2010 Jul; 62(7):2152-9. PubMed ID: 20506150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.
    Saadoun D; Delluc A; Piette JC; Cacoub P
    Curr Opin Rheumatol; 2008 Jan; 20(1):23-8. PubMed ID: 18281853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis.
    Landau DA; Rosenzwajg M; Saadoun D; Trébeden-Negre H; Klatzmann D; Cacoub P
    Arthritis Rheum; 2008 Sep; 58(9):2897-907. PubMed ID: 18759287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.
    Sneller MC; Hu Z; Langford CA
    Arthritis Rheum; 2012 Mar; 64(3):835-42. PubMed ID: 22147444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus-related cryoglobulinemic vasculitis.
    Mazzaro C; Mauro E; Ermacora A; Doretto P; Fumagalli S; Tonizzo M; Toffolutti F; Gattei V
    Minerva Med; 2021 Apr; 112(2):175-187. PubMed ID: 33198444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements.
    Dammacco F; Lauletta G; Vacca A
    Clin Exp Med; 2023 Jun; 23(2):255-272. PubMed ID: 35348938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of programmed cell death protein 1 and T-cell immunoglobulin- and mucin-domain-containing molecule-3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus.
    Caraballo Cortés K; Osuch S; Perlejewski K; Pawełczyk A; Kaźmierczak J; Janiak M; Jabłońska J; Nazzal K; Stelmaszczyk-Emmel A; Berak H; Bukowska-Ośko I; Paciorek M; Laskus T; Radkowski M
    J Viral Hepat; 2019 Aug; 26(8):942-950. PubMed ID: 30972915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis.
    Comstock E; Kim CW; Murphy A; Emmanuel B; Zhang X; Sneller M; Poonia B; Kottilil S
    PLoS One; 2017; 12(12):e0188314. PubMed ID: 29228031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
    Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D
    Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.
    Ferri C; Cacoub P; Mazzaro C; Roccatello D; Scaini P; Sebastiani M; Tavoni A; Zignego AL; De Vita S
    Autoimmun Rev; 2011 Nov; 11(1):48-55. PubMed ID: 21821153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC).
    Quartuccio L; Bortoluzzi A; Scirè CA; Marangoni A; Del Frate G; Treppo E; Castelnovo L; Saccardo F; Zani R; Candela M; Fraticelli P; Mazzaro C; Renoldi P; Scaini P; Filippini DA; Visentini M; Scarpato S; Giuggioli D; Mascia MT; Sebastiani M; Zignego AL; Lauletta G; Fiorilli M; Casato M; Ferri C; Pietrogrande M; Pioltelli PE; De Vita S; Monti G; Galli M
    Clin Rheumatol; 2023 Feb; 42(2):359-370. PubMed ID: 36169798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR9 signalling in HCV-associated atypical memory B cells triggers Th1 and rheumatoid factor autoantibody responses.
    Comarmond C; Lorin V; Marques C; Maciejewski-Duval A; Joher N; Planchais C; Touzot M; Biard L; Hieu T; Quiniou V; Desbois AC; Rosenzwajg M; Klatzmann D; Cacoub P; Mouquet H; Saadoun D
    J Hepatol; 2019 Nov; 71(5):908-919. PubMed ID: 31279905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?
    Cacoub P; Delluc A; Saadoun D; Landau DA; Sene D
    Ann Rheum Dis; 2008 Mar; 67(3):283-7. PubMed ID: 17644544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature.
    Giuggioli D; Manfredi A; Colaci M; Manzini CU; Antonelli A; Ferri C
    Autoimmun Rev; 2013 Sep; 12(11):1058-63. PubMed ID: 23806565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute wrist and foot drop associated with hepatitis C virus related mixed cryoglobulinemia: rapid response to treatment with rituximab.
    Uppal R; Charles E; Lake-Bakaar G
    J Clin Virol; 2010 Jan; 47(1):69-71. PubMed ID: 19892591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.